| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/14/2014 | CA2548771C A medical solution, a method for producing said medical solution and use thereof |
| 01/14/2014 | CA2538691C Process for producing polysaccharide for conjugate vaccine |
| 01/14/2014 | CA2439925C Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 01/14/2014 | CA2342243C Stable liquid formulations of botulinum toxin |
| 01/09/2014 | WO2014008375A1 Terminally modified polymers and conjugates thereof |
| 01/09/2014 | WO2014008334A1 Stable non-aggregating nucleic acid lipid particle formulations |
| 01/09/2014 | WO2014008176A2 Pearl sugar particle, composition, and process for preparing a pearl sugar |
| 01/09/2014 | WO2014007517A1 Ph sensitive fluorescent polydiacetylene liposome and drug delivery vehicle comprising same |
| 01/09/2014 | WO2014007463A1 Orally administered preparation whereby bioavailability of megestrol acetate is improved and method for improving bioavailability of orally administered megestrol acetate |
| 01/09/2014 | WO2014007398A1 Cationic lipid |
| 01/09/2014 | WO2014007266A1 Transdermal cancer antigen peptide preparation |
| 01/09/2014 | WO2014007239A1 Composition containing amphotericin b |
| 01/09/2014 | WO2014007065A1 Solid pharmaceutical tablet, and method for producing same |
| 01/09/2014 | WO2014006867A1 Composition containing biologically active substance |
| 01/09/2014 | WO2014006576A1 Pharmaceutical compositions comprising rifaximin and amino acids, preparation method and use thereof |
| 01/09/2014 | WO2014006532A1 Capsules containing thymoquinone |
| 01/09/2014 | WO2014006502A1 Protozoan variant-specific surface proteins (vsp) as carriers for oral drug delivery |
| 01/09/2014 | WO2014006349A1 Lipiodol-based anti-tumour emulsion for treating cancer |
| 01/09/2014 | WO2014006318A1 Method for producing haemophilus influenzae type b antigens |
| 01/09/2014 | WO2014006254A1 Nanoparticles coated with gelatin |
| 01/09/2014 | WO2014006215A1 Hydrogel vaccine formulations |
| 01/09/2014 | WO2014006124A1 Covalently linked antigen-antibody conjugates |
| 01/09/2014 | WO2014006113A1 Method of treating cancer by effective amounts of aflibercept |
| 01/09/2014 | WO2014006082A1 Conjugates containing sequences from placenta growth factor and their use as components of biomaterials and in medicine |
| 01/09/2014 | WO2014005596A1 Modified payload molecules and their interactions and uses |
| 01/09/2014 | WO2014005471A1 Thermosensitive injectable chitosan hydrogel product and use thereof |
| 01/09/2014 | WO2014005363A1 2,2',6,6'-tetraisopropyl-4,4'-2-biphenol soft capsule and method for preparing same |
| 01/09/2014 | WO2014005314A1 Bone-targeted delivery system for osteogenesis treatment based on small nucleic acid medicine and preparation method thereof |
| 01/09/2014 | WO2014005219A1 Intracellular protein delivery |
| 01/09/2014 | WO2013173834A3 Trigger-responsive chain-shattering polymers |
| 01/09/2014 | WO2013164652A3 Microspheres for treating helicobacter pylori infections |
| 01/09/2014 | US20140012271 Polymeric bone foam composition and method |
| 01/09/2014 | US20140011964 Activated Polyoxazolines and Conjugates and Compositions Comprising the Same |
| 01/09/2014 | US20140011893 Composition and method |
| 01/09/2014 | US20140011892 Pearl sugar particle, composition, and process for preparing a pearl sugar |
| 01/09/2014 | US20140011891 MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES |
| 01/09/2014 | US20140011885 Organic Compounds |
| 01/09/2014 | US20140011871 Antifungal serum |
| 01/09/2014 | US20140011869 Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions |
| 01/09/2014 | US20140011855 Polymer-semaxanib moiety conjugates |
| 01/09/2014 | US20140011854 ST-246 Liquid Formulations and Methods |
| 01/09/2014 | US20140011843 Methods for stabilizing oxidatively unstable compositions |
| 01/09/2014 | US20140011788 Pharmaceutical composition and method for treating hypogonadism |
| 01/09/2014 | US20140011776 Novel fatty acid-salicylate conjugates with enhanced therapeutic properties |
| 01/09/2014 | US20140011760 Novel Polymers and the Preparation of Nanogel Drug Cocktails |
| 01/09/2014 | US20140011741 Hemoglobin compositions |
| 01/09/2014 | US20140011739 Protozoan variant-specific surface proteins (vsp) as carriers for oral drug delivery |
| 01/09/2014 | US20140010903 Curcuminoid composition with enhanced bioavailability and a process for its preparation |
| 01/09/2014 | US20140010902 Excipient system for topical delivery of pharmaceutical agents |
| 01/09/2014 | US20140010900 Pharmaceutical composition containing active vegetable substances |
| 01/09/2014 | US20140010886 Compositions comprising saccharide binding moieties and methods for targeted therapy |
| 01/09/2014 | US20140010884 Dermatological compositions comprising retinoids, dispersed benzoyl peroxide and carrageenans |
| 01/09/2014 | US20140010881 Low surfactant iodine topical disinfectant |
| 01/09/2014 | US20140010880 Tricalcium Phosphate Coarse Particle Compositions and Methods for Making the Same |
| 01/09/2014 | US20140010879 Compositions and methods of treating therapy resistant cancer and uses thereof |
| 01/09/2014 | US20140010862 Multifunctional biodegradable peg nanocarrier-based hydrogels for preventing hiv transmission |
| 01/09/2014 | US20140010798 Albumin fusion proteins |
| 01/09/2014 | US20140010795 Formulation and method for the prevention and treatment of bone metastases or other bone diseases |
| 01/09/2014 | US20140010771 Allantoin-Containing Skin Cream |
| 01/09/2014 | US20140010759 Tumor specific anitbodies and uses therefor |
| 01/09/2014 | US20140010756 Composition for treatment and diagnosis of pancreatic cancer |
| 01/09/2014 | US20140008264 Biodegradable Natural Films Based on Co-Products Derived from Industrial-Scale Seed-Treatment Processes |
| 01/09/2014 | US20140007873 Dry powder inhaler and system for drug delivery |
| 01/09/2014 | CA2878322A1 Protozoan variant-specific surface proteins (vsp) as carriers for oral drug delivery |
| 01/09/2014 | CA2878292A1 Potentiation of antibiotic treatment with a protein-lipid complex |
| 01/09/2014 | CA2878128A1 Hydrogel vaccine formulations |
| 01/09/2014 | CA2878100A1 Conjugates containing sequences from placenta growth factor and their use as components of biomaterials and in medicine |
| 01/09/2014 | CA2878053A1 Method for producing haemophilus influenzae type b antigens |
| 01/09/2014 | CA2877393A1 Compositions comprising sulforaphane or a sulforaphane precursor and ursolic acid |
| 01/09/2014 | CA2877384A1 Intracellular protein delivery |
| 01/09/2014 | CA2877356A1 Compositions comprising a sulforaphane or a sulforaphane precursor and milk thistle extract or powder |
| 01/09/2014 | CA2877338A1 Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder |
| 01/09/2014 | CA2877329A1 Compositions comprising sulforaphane or a sulforaphane precursor and magnesium |
| 01/09/2014 | CA2874815A1 Pharmaceutical compositions comprising rifaximin and amino acids, preparation method and use thereof |
| 01/08/2014 | EP2682409A1 Hyaluronic acid derivative modified by amino-carbonic acid |
| 01/08/2014 | EP2682401A1 Drug delivery material capable of passing through blood-brain barrier, and peptide and use thereof |
| 01/08/2014 | EP2682130A1 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 01/08/2014 | EP2682122A1 Growth hormone secretion promoter |
| 01/08/2014 | EP2682106A1 Method of solubilizing biologically active compounds |
| 01/08/2014 | EP2682094A1 Manufacturing method for o/w emulsion composition |
| 01/08/2014 | EP2680899A2 Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
| 01/08/2014 | EP2680887A1 Dipyridinium derivatives |
| 01/08/2014 | EP2680846A1 Use of n-(4-methoxyphenyl)-1-phenyl-1h-pyrazol-3-amine and related compounds |
| 01/08/2014 | EP2680828A1 Chewable vehicle for mouth absorption |
| 01/08/2014 | EP2680827A1 Particles containing a growth factor, and uses thereof |
| 01/08/2014 | EP2680825A1 Prucalopride oral solution |
| 01/08/2014 | EP2680822A1 Vesicle compositions |
| 01/08/2014 | EP2680820A1 Advanced active liposomal loading of poorly water-soluble substances |
| 01/08/2014 | EP2680818A1 Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols |
| 01/08/2014 | EP2680817A2 Use of a viscoelastic fluid for producing a medicinal product for surgically treating the eye |
| 01/08/2014 | EP2680815A1 Porous disintegratable solid substrate for personal health care applications |
| 01/08/2014 | CN103501821A Targeted nanocarrier systems for delivery of actives across biological membranes |
| 01/08/2014 | CN103501820A Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells |
| 01/08/2014 | CN103501819A Bisphosphonate-prodrugs |
| 01/08/2014 | CN103501818A Methods and reagents for efficient and targeted delivery of therapeutic molecules to cxcr4 cells |
| 01/08/2014 | CN103501817A Novel polysaccharide derivatives and dosage forms |
| 01/08/2014 | CN103501813A Tolerogenic synthetic nanocarriers to reduce antibody responses |
| 01/08/2014 | CN103501810A Enhanced immune response in bovine species |
| 01/08/2014 | CN103501800A Beautiful-skin-promoting agent and use thereof |
| 01/08/2014 | CN103501794A Brain-targeting functional nucleic acid and use thereof |